SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-033745
Filing Date
2023-09-26
Accepted
2023-09-26 16:30:10
Documents
13
Period of Report
2023-09-21
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 38042
2 ex10-1.htm EX-10.1 116861
  Complete submission text file 0001493152-23-033745.txt   354724

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE ghsi-20230921.xsd EX-101.SCH 3033
4 XBRL LABEL FILE ghsi-20230921_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE ghsi-20230921_pre.xml EX-101.PRE 22371
7 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3428
Mailing Address 2925 RICHMOND AVENUE SUITE 1200 HOUSTON TX 77098
Business Address 2925 RICHMOND AVENUE SUITE 1200 HOUSTON TX 77098 (800) 873-5141
Guardion Health Sciences, Inc. (Filer) CIK: 0001642375 (see all company filings)

IRS No.: 474428421 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38861 | Film No.: 231280803
SIC: 2834 Pharmaceutical Preparations